Skip to main content
. 2020 Oct 28;34(1):e00043-19. doi: 10.1128/CMR.00043-19

TABLE 8.

Selected CMV vaccine candidates for prevention of CMV infection in transplant recipients

Candidate Type of vaccine Target(s) Reference(s)
gB Recombinant protein gB 168
MVA Triplex Vector (MVA) pp65, IE1-exon 4, and IE2-exon 5 174, 279
HB-101 Vector (LCMV) gB and pp65 175
ASP0113 DNA gB and pp65 132, 169
PepVax Chimeric peptide pp65 171, 172
ALVAC-pp65 Vector (canarypox virus) pp65 280, 281
Towne Attenuated strain Whole virus 282